Ekin Selami, Arısoy Ahmet, Gunbatar Hulya, Sertogullarindan Bunyamin, Sunnetcioglu Aysel, Sezen Hatice, Asker Selvi, Yıldız Hanifi
a Yuzuncu Yıl University, Pulmonary Medicine , 65080 Van , Turkey.
b Department of Biochemistry , Harran University , Turkey.
Redox Rep. 2017 Mar;22(2):74-77. doi: 10.1080/13510002.2016.1139293. Epub 2016 Feb 15.
Chronic obstructive pulmonary disease (COPD) is a progressive condition characterized by poorly reversible airflow limitations associated with an abnormal inflammatory response of the lung.
We investigated whether prolidase levels in serum, total antioxidant status, total oxidative status (TOS), and the oxidative stress index (OSI) were associated with the etiopathogenesis of COPD, and whether there is a relationship between prolidase activity and oxidative parameters and carotid artery intima-media thickness (CIMT) in patients with COPD. This study included 91 patients with COPD and 15 control cases. Routine haematological and biochemical parameters were determined in all patients. All subjects were fully informed about the study and provided consent.
The mean age of the patients with COPD was 61.3 ± 10.5 years and that of the control group was 56.2 ± 12.1 years. The control group had a significantly higher plasma prolidase level than that in the COPD group. TOS and OSI levels in the control group were significantly lower than those in the COPD group. However, no significant differences were found in TALs or CIMT levels between the COPD and control groups. A negative correlation was detected between prolidase activity and age; however, no significant difference in age was observed between the two groups.
These results indicate that prolidase activity decreases in patients with COPD.
慢性阻塞性肺疾病(COPD)是一种进行性疾病,其特征为气流受限可逆性差,并伴有肺部异常炎症反应。
我们调查了血清中脯氨酰二肽氨基肽酶水平、总抗氧化状态、总氧化状态(TOS)以及氧化应激指数(OSI)是否与COPD的发病机制相关,以及COPD患者的脯氨酰二肽氨基肽酶活性与氧化参数及颈动脉内膜中层厚度(CIMT)之间是否存在关系。本研究纳入了91例COPD患者和15例对照病例。测定了所有患者的常规血液学和生化参数。所有受试者均充分了解该研究并签署了知情同意书。
COPD患者的平均年龄为61.3±10.5岁,对照组的平均年龄为56.2±12.1岁。对照组的血浆脯氨酰二肽氨基肽酶水平显著高于COPD组。对照组的TOS和OSI水平显著低于COPD组。然而,COPD组和对照组之间的TALs或CIMT水平未发现显著差异。脯氨酰二肽氨基肽酶活性与年龄呈负相关;然而,两组之间的年龄未观察到显著差异。
这些结果表明COPD患者的脯氨酰二肽氨基肽酶活性降低。